强制降级
活性成分
化学
降级(电信)
杂质
成分
药品
生化工程
药物
设计质量
色谱法
药理学
有机化学
计算机科学
食品科学
高效液相色谱法
粒径
甲酸铵
物理化学
工程类
电信
医学
作者
Ana Carolina Kogawa,Hérida Regina Nunes Salgado
出处
期刊:Current Pharmaceutical Analysis
[Bentham Science]
日期:2015-11-03
卷期号:12 (1): 18-24
被引量:19
标识
DOI:10.2174/1573412911666150519000155
摘要
The safety of pharmaceuticals is dependent not only on the intrinsic toxicological properties of the active ingredient, but also on the impurities and degradation products that it may contain. The presence of impurities in active ingredients can have a significant impact on the quality, safety and efficacy of pharmaceuticals. Efforts should be made to identify and characterize all unknown impurities in the drug, due to the increasing demand of regulatory agencies to manufacture high-purity drugs. The drug impurity profile is one of the most important issues in modern pharmaceutical analysis during the process of technology development for the production of high-purity substances. The degradation products may be provided through forced degradation studies, which enable development of indicators of stability methods with appropriate specificity and selectivity, purity verification chromatographic peak of active pharmaceutical ingredient in the product, provides information about possible degradation routes of a certain product, evaluation of the factors that may interfere in any way in the drug stability and critical analysis of the drug degradation profile. Keywords: Degradation products, degradation profile, forced degradation, impurities, quality, pharmaceuticals.
科研通智能强力驱动
Strongly Powered by AbleSci AI